NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-037-2016-0-JP-07 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS JP National Stage 2018-530502 Issued
NIAID E-050-2018-0-US-01 NIPAH VIRUS IMMUNOGENS AND THEIR USE US 62/714,230 Abandoned
NIBIB E-005-2012-2-US-07 MULTI-FOCAL STRUCTURED ILLUMINATION MICROSCOPY SYSTEMS AND METHODS US CON 16/053,533 10281702 Issued PDF
NIAID E-005-2017-0-PCT-02 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS PCT PCT PCT/US2018/045032 Expired
NIAID E-005-2017-0-CN-03 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS CN National Stage 201880063622.5 Pending
NIAID E-005-2017-0-EP-04 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS EP National Stage 18756111.3 Pending
NIAID E-005-2017-0-IN-05 HEPATITIS B NANOPARTICLE-BASED VACCINE FOR INFLUENZA VIRUS IN National Stage 202017008138 Pending
NIAID E-257-2015-0-US-03 COMPOUNDS FOR MODULATING FC-EPSILON-RI-BETA EXPRESSION AND USES THEREOF US CON 16/052,130 11268096 Issued PDF
NCI E-230-2011-1-US-20 VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS US CON 16/051,062 11434268 Issued PDF
NICHD E-552-2013-0-GB-27 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE GB EP 18186594.0 Issued
NICHD E-552-2013-0-EP-14 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE EP DIV 18186594.0 Issued
NICHD E-552-2013-0-DE-25 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE DE EP 18186594.0 Issued
NICHD E-552-2013-0-FR-26 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE FR EP 18186594.0 Issued
NHLBI E-124-2014-3-US-04 Device For Closure Of Transvascular Or Transcameral Access Ports US CON 16/049,946 Abandoned
NCI E-035-2021-0-HU-01 A Method For The Early Detection Of Breast Cancer HU ORD P1800271 Pending
NHLBI E-222-2022-4-US-01 Catheters and Manipulators with Deflectable Ends US 62/712,194 Expired
NCI E-193-2017-0-PCT-02 Ultrasound Sensitive Peptide Particles For Spatially Resolved Molecule Delivery PCT PCT PCT/US2018/044382 Expired
NHLBI E-758-2013-1-US-05 ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF US CON 16/047,929 11384139 Issued PDF
NCI E-105-2012-0-JP-13 Murine Anti-NY-ESO-1 T Cell Receptors JP DIV 2018-139890 Abandoned
NCI E-181-2018-0-CN-01 Discovery, Synthesis And Evaluation Of Oxynitidine Derivatives As Dual Inhibitors Of DNA Topoisomerase IB (TOP1) And Tyrosyl-DNA Phosphodiesterase 1 (TDP1), And Potential Antitumor Agents CN ORD 201810827467.1 Pending
NLM E-111-2016-7-CA-03 Novel CRISPR Enzymes And Systems CA National Stage 3012631 Pending
NIAID E-051-2012-3-US-11 BROADLY NEUTRALIZING HIV-1 ANTIBODIES THAT BIND TO THE CD4-BINDING SITE OF THE ENVELOPE PROTEIN US DIV 16/044,083 10815295 Issued PDF
NCATS E-004-2016-0-CN-05 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CN National Stage 201680079771.1 Issued
NIAID E-099-2016-1-US-01 JSE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CIP 16/042,939 10293005 Abandoned PDF
NCI E-148-2011-0-JP-16 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer JP DIV 2018-137193 Issued
NCI E-010-2008-0-US-05 METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY US CON 16/041,395 10577397 Issued PDF
NCI E-205-2010-2-JP-12 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2018-136580 Pending
NEI E-164-2018-0-US-01 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS US 62/701,267 Abandoned
NIAMS E-192-2017-0-HK-07 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION HK EP 62020019675.1 Issued
NHLBI E-055-2019-0-US-01 ApoE-ApoCII Chimeric Peptides US 62/700,751 Abandoned
NIAMS E-192-2017-0-PCT-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION PCT PCT PCT/US2018/042870 Expired
NCI E-089-2016-0-EP-03 Niclosamide Therapy For Adrenal Cancer EP National Stage 17702246.4 Abandoned
NCI E-040-2012-0-ID-28 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen ID DIV P-00201805294 Pending
NINDS E-143-2002-1-HK-76 Method For the Treatment of Multiple Sclerosis HK EP 18109281.9 Abandoned
NCI E-089-2016-0-US-04 TREATMENT OF MALIGNANT ADRENOCORTICAL TUMOR WITH NICLOSAMIDE
AND OTHER COMPOUNDS 		US National Stage 16/070,374 Abandoned
NCI E-227-2006-5-EP-13 PREVENTION OF TISSUE ISCHEMIA, RELATED METHODS AND COMPOSITIONS EP DIV 18183780.8 Abandoned
NHGRI E-164-2020-0-US-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS US 62/698,528 Abandoned
NCI E-011-2019-0-US-01 Cell Linkers for Heterotypic Cell Spheroids US 62/698,602 Abandoned
NCI E-520-2013-0-US-18 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US DIV 16/034,654 10508141 Issued PDF
NCI E-154-2018-0-US-01 BINARY LIPID BILAYER-CONTAINING VESICLES COMPRISING EMBEDDED CYTOTOXIC AGENTS AND METHODS OF MAKING AND USING THE SAME US 62/697,287 Abandoned
NCI E-161-2018-0-US-01 AFFINITY MATURED CD22-SPECIFIC MONOCLONAL ANTIBODY AND USES THEREOF US 62/697,185 Abandoned
NCI E-075-2018-1-US-01 HEXAMERIC TETRAHEDRAL RNA NANOSTRUCTURES US 62/696,619 Abandoned
NHGRI E-275-2015-0-EP-03 Gene Therapy For Combined Methylmalonic Acidermia/Aciduria and Hyperhomocysteinemia/Homocystinuria, Cobalamin C Type and Deficiency of MMACHC EP National Stage 16721331.3 Pending
NIAID E-037-2016-0-KR-08 RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS KR National Stage 10-2018-7019755 Pending
NIAMS E-216-2010-0-US-08 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING LUPUS US DIV 16/030,185 10907151 Issued PDF
NCATS E-023-2016-0-US-08 Antifungal Compound Process US DIV 16/030,228 10421741 Issued PDF
NIDDK E-121-2019-2-US-02 METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE US CON 16/030,818 Abandoned
NIA E-151-2017-0-EP-06 FATTY ACID DERIVATIVES AND THEIR USE EP National Stage 18746415.1 Issued
NIA E-151-2017-0-GB-01 FATTY ACID DERIVATIVES AND THEIR USE GB EP 18746415.1 Issued
NIA E-151-2017-0-CA-04 FATTY ACID DERIVATIVES AND THEIR USE CA National Stage 3064132 Issued